Basic Information
Vignette Bio Focuses on Innovative Therapies for Immunology and Inflammation-Related DiseasesVignette Bio is incubated by Foresite Labs, a platform led by a team of experienced scientists, engineers, and operators who believe that the rigorous application of data science tools will significantly accelerate scientific discoveries and the development of new products and services to benefit patients. Vignette Bio is supported by Foresite Capital, Qiming Venture Partners USA, Samsara BioCapital, and Mirae Asset Capital's Life Science Division.
Vignette Bio, Inc.
United States of America
unclear
January 01, 2024
--
--

